Completed PHASE3 INTERVENTIONAL 2-arm NCT04122547

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis: a Randomized Double-blind Placebo-controlled Trial

Sponsor: Prince of Songkla University

Conditions Bronchiectasis Exacerbation Copd Lung Function Decreased

Interventions Placebo Roflumilast

Updated 4 times since 2019 Last updated: Oct 9, 2019 Started: Jan 31, 2015 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Bronchiectasis and Exacerbation Copd, this trial is completed. The trial is conducted by Prince of Songkla University and has accumulated 4 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2019 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prince of Songkla University

Data source: Prince of Songkla University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Songkhla, Thailand